Trials / Completed
CompletedNCT00536393
Treatment of Disseminated High Grade Lymphoma
Phase III Study of Treatment of Disseminated and Agressive Lymphoma R CHOP Versus R CLOP( With Liposomal Doxorubicin)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- French Innovative Leukemia Organisation · Academic / Other
- Sex
- All
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Interest of the use of pegylated liposomal doxorubicin (caélyx)
Detailed description
R CHOP is a good standard in the treatment of diffuse high grade lymphoma. Howeverin elderly patients it is often toxic, specially with haematologic and cardiac toxicities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxorubicin | |
| DRUG | Doxorubicin pegylated |
Timeline
- Start date
- 2000-10-01
- Completion
- 2004-10-01
- First posted
- 2007-09-27
- Last updated
- 2007-11-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00536393. Inclusion in this directory is not an endorsement.